Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
For the second time in four years, Grifols SA has said it received notice from the Justice Department that an investigation into possible FCPA violations has been closed and the company won’t be prosecuted.… Continue Reading
Spanish pharma Grifols S.A described ongoing corruption investigations across Europe and in South America and Asia in a recent SEC filing.
Some of the investigations relate to sales practices by Talecris Biotherapeutics.… Continue Reading
In an SEC filing this week, Spanish pharmaceutical firm Grifols SA said the DOJ issued an ‘official declination to all inquiries related to the possible violation of the Foreign Corrupt Practices Act (FCPA) that were underway since July 2009.’… Continue Reading
